PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,166,060 | +395.5% | 52,033 | +799.3% | 0.00% | +300.0% |
| Q2 2023 | $235,317 | -74.5% | 5,786 | -69.7% | 0.00% | -66.7% |
| Q1 2023 | $924,090 | +13899.2% | 19,077 | -89.0% | 0.00% | -87.5% |
| Q4 2022 | $6,601 | -99.9% | 172,938 | +33.8% | 0.02% | -4.0% |
| Q3 2022 | $6,487,000 | +1580.6% | 129,222 | +1242.0% | 0.02% | +2400.0% |
| Q2 2022 | $386,000 | -90.7% | 9,629 | -91.3% | 0.00% | -90.9% |
| Q1 2022 | $4,138,000 | +441.6% | 110,908 | +478.1% | 0.01% | +450.0% |
| Q4 2021 | $764,000 | -77.7% | 19,185 | -73.5% | 0.00% | -85.7% |
| Q1 2021 | $3,428,000 | -22.4% | 72,400 | 0.0% | 0.01% | -26.3% |
| Q4 2020 | $4,419,000 | -64.6% | 72,400 | -72.9% | 0.02% | -72.9% |
| Q3 2020 | $12,496,000 | +153.3% | 267,300 | +160.2% | 0.07% | +125.8% |
| Q4 2019 | $4,934,000 | – | 102,737 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |